{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T10:09:38Z","timestamp":1778753378155,"version":"3.51.4"},"reference-count":167,"publisher":"Knowledge E DMCC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Ophthalmic Vis Res"],"published-print":{"date-parts":[[2019]]},"DOI":"10.4103\/jovr.jovr_86_18","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T09:29:30Z","timestamp":1555666170000},"page":"195","source":"Crossref","is-referenced-by-count":18,"title":["Ocular manifestations and management of autoimmune bullous diseases"],"prefix":"10.18502","volume":"14","author":[{"given":"Sepehr","family":"Feizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danial","family":"Roshandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7770","reference":[{"key":"key-10.4103\/2008-322X.256557-1","first-page":"651\u2013658","volume-title":"The dermal-epidermal junction","author":"Burgeson","year":"1997","journal-title":"Curr Opin Cell Biol"},{"key":"key-10.4103\/2008-322X.256557-2","first-page":"869\u2013877","volume-title":"Autoantibodies against a novel epithelial cadherin in pemphigus vulgaris, a disease of cell adhesion","author":"Amagai","year":"1991","journal-title":"Cell"},{"key":"key-10.4103\/2008-322X.256557-3","first-page":"323\u2013330","volume-title":"Immunomorphological and biochemical identification of the pemphigus foliaceus autoantigen within desmosomes","author":"Rappersberger","year":"1992","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-4","first-page":"409\u2013415","volume-title":"Pemphigus vulgaris antigen, a desmoglein type of cadherin, is localized within keratinocyte desmosomes","author":"K\u00e1rp\u00e1ti","year":"1993","journal-title":"J Cell Biol"},{"key":"key-10.4103\/2008-322X.256557-5","first-page":"291\u2013325","volume-title":"Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion","author":"Stanley","year":"1993","journal-title":"Adv Immunol"},{"key":"key-10.4103\/2008-322X.256557-6","first-page":"870\u2013878","volume-title":"Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen","author":"Sitaru","year":"2005","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-7","first-page":"861\u2013875","volume-title":"Mechanisms of blister induction by autoantibodies","author":"Sitaru","year":"2005","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/2008-322X.256557-8","first-page":"538\u2013541","volume-title":"Brazilian pemphigus foliaceus autoantibodies are pathogenic to BALB\/c mice by passive transfer","author":"Roscoe","year":"1985","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-9","first-page":"1189\u20131196","volume-title":"Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease","author":"Anhalt","year":"1982","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-322X.256557-10","first-page":"345\u2013362","volume-title":"Epidermal acantholysis induced in vitro by pemphigus autoantibody.An ultrastructural study","author":"Hu","year":"1978","journal-title":"Am J Pathol"},{"key":"key-10.4103\/2008-322X.256557-11","first-page":"106\u2013112","volume-title":"End of the century overview of skin blisters","author":"Diaz","year":"2000","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-12","first-page":"1443\u20131448","volume-title":"Pemphigus and pemphigoid as paradigms of organ-specific, autoantibody-mediated diseases","author":"Stanley","year":"1989","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-13","first-page":"1256\u20131263","volume-title":"A major role for neutrophils in experimental bullous pemphigoid","author":"Liu","year":"1997","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-14","first-page":"2480\u20132488","volume-title":"A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP 180","author":"Liu","year":"1993","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-15","first-page":"41\u201360","volume-title":"Cicatricial pemphigoid: Diagnosis and treatment","author":"Nguyen","year":"1996","journal-title":"Int Ophthalmol Clin"},{"key":"key-10.4103\/2008-322X.256557-16","first-page":"223\u2013229","volume-title":"Long-term results of systemic chemotherapy for ocular cicatricial pemphigoid","author":"Foster","year":"1992","journal-title":"Doc Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-17","first-page":"320\u2013332","volume-title":"Pemphigoid diseases","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"key-10.4103\/2008-322X.256557-18","first-page":"656\u2013662","volume-title":"Bullous pemphigoid, cicatricial pemphigoid, and pemphigus vulgaris.A comparative clinical survey of 278 cases","author":"Laskaris","year":"1982","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/2008-322X.256557-19","first-page":"11579\u201311582","volume-title":"Association of DQw7 (DQB1 * 0301) with ocular cicatricial pemphigoid","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.256557-20","first-page":"202\u2013207","volume-title":"Ocular cicatricial pemphigoid.A case report of monozygotic twins discordant for the disease","author":"Bhol","year":"1995","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-21","first-page":"99\u2013101","volume-title":"High frequency of HLA-DQB1 * 0301 allele in patients with pure ocular cicatricial pemphigoid","author":"Chan","year":"1994","journal-title":"Dermatology"},{"key":"key-10.4103\/2008-322X.256557-22","first-page":"697\u2013705","volume-title":"Benign mucous membrane pemphigoid (cicatricial mucosal pemphigoid): A reconsideration","author":"Foster","year":"1977","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/2008-322X.256557-23","first-page":"370\u2013379","volume-title":"The first international consensus on mucous membrane pemphigoid: Definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators","author":"Chan","year":"2002","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-24","first-page":"45\u201352","volume-title":"Mucous membrane pemphigoid and pseudopemphigoid","author":"Thorne","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-25","first-page":"191\u2013200","volume-title":"Mucous membrane pemphigoid: Clinical aspects, immunopathological features and therapy","author":"Bruch-Gerharz","year":"2007","journal-title":"Eur J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-26","first-page":"340\u2013353","volume-title":"Immunosuppressive therapy for progressive ocular cicatricial pemphigoid","author":"Foster","year":"1982","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-27","first-page":"2136\u20132143","volume-title":"Intravenous immunoglobulin therapy for ocular cicatricial pemphigoid: A preliminary study","author":"Foster","year":"1999","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-28","first-page":"1283\u20131288","volume-title":"Long-term results of mucous membrane grafting in ocular cicatricial pemphigoid.Implications for patient selection and surgical considerations","author":"Heiligenhaus","year":"1993","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-29","first-page":"2631\u20132636","volume-title":"Antigen specificity in subsets of mucous membrane pemphigoid","author":"Rashid","year":"2006","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-30","first-page":"307\u2013314","volume-title":"The relationship between linear IgA disease and benign mucous membrane pemphigoid","author":"Leonard","year":"1984","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-31","first-page":"52\u201356","volume-title":"Conjunctival involvement in cicatricial and bullous pemphigoid: A clinical and immunopathological study","author":"Frith","year":"1989","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-32","first-page":"7\u201315","volume-title":"Mucosal involvement in bullous and cicatricial pemphigoid.A clinical and immunopathological study","author":"Venning","year":"1988","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-33","first-page":"499\u2013510","volume-title":"Cicatricial pemphigoid","author":"Mutasim","year":"1993","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/2008-322X.256557-34","first-page":"527\u2013663","volume-title":"Cicatricial pemphigoid","author":"Foster","year":"1986","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.4103\/2008-322X.256557-35","first-page":"891\u2013986","volume-title":"Cultured corneal epithelia for ocular surface disease","author":"Schwab","year":"1999","journal-title":"Trans Am Ophthalmol Soc"},{"key":"key-10.4103\/2008-322X.256557-36","first-page":"574\u2013583","volume-title":"Conjunctival changes associated with glaucoma therapy: Implications for the external disease consultant and the treatment of glaucoma","author":"Liesegang","year":"1998","journal-title":"Cornea"},{"key":"key-10.4103\/2008-322X.256557-37","doi-asserted-by":"crossref","first-page":"111\u2013122","DOI":"10.1159\/isbn.978-3-318-00231-7","volume-title":"Monitoring of activity and progression in cicatrising conjunctivitis","author":"Elder","year":"1997","journal-title":"Dev Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-38","first-page":"95\u2013100","volume-title":"Ocular cicatricial pemphigoid","author":"Mondino","year":"1981","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-39","first-page":"446\u2013451","volume-title":"Improved detection of disease progression in ocular cicatricial pemphigoid","author":"Tauber","year":"1992","journal-title":"Cornea"},{"key":"key-10.4103\/2008-322X.256557-40","first-page":"179\u2013184","volume-title":"A new method for measuring progression in patients with ocular cicatricial pemphigoid","author":"Rowsey","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-41","first-page":"611\u2013618","volume-title":"Ocular and oral grading of mucous membrane pemphigoid","author":"Reeves","year":"2012","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-42","first-page":"259\u2013266","volume-title":"Current medical treatment of ocular mucous membrane pemphigoid","author":"Sobolewska","year":"2013","journal-title":"Ocul Surf"},{"key":"key-10.4103\/2008-322X.256557-43","first-page":"285\u2013290","volume-title":"Drug-induced ocular cicatricial pemphigoid: A series of clinico-pathological reports","author":"Butt","year":"1998","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2008-322X.256557-44","first-page":"371\u2013378","volume-title":"Chronic progressive conjunctival cicatrisation","author":"Bernauer","year":"1993","journal-title":"Eye (Lond)"},{"key":"key-10.4103\/2008-322X.256557-45","doi-asserted-by":"crossref","unstructured":"Fine JD. Cicatricial pemphigoid. In: Wojnarowska F, Briggaman RA, editors. Management of Blistering Diseases. New York: Raven Press; 1990. p. 83\u201392.","DOI":"10.1007\/978-1-4899-7190-6_6"},{"key":"key-10.4103\/2008-322X.256557-46","first-page":"339\u2013346","volume-title":"The conjunctiva in acute and chronic mucous membrane pemphigoid.An immunohistochemical analysis","author":"Bernauer","year":"1993","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-47","first-page":"535\u2013540","volume-title":"Benign mucous membrane pemphigoid.An unusual case with electron microscopic findings","author":"Brauner","year":"1972","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-48","first-page":"631\u2013660","volume-title":"Clinical and immunopathological correlation in cicatricial pemphigoid: A study of 36 cases.British Society for Investigative Dermatology Annual Meeting, Oxford, April 6\u20137, 1995","author":"Setterfield","year":"1995","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-49","first-page":"1158\u20131163","volume-title":"Increasing the diagnostic yield of conjunctival biopsy in patients with suspected ocular cicatricial pemphigoid","author":"Power","year":"1995","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-50","first-page":"805\u2013950","volume-title":"Direct immunoelectron microscopy on the conjunctiva in ocular cicatricial pemphigoid versus subepidermal autoimmune bullous dermatoses with ocular involvement: Report of 10 cases.Abstracts for the 1996 Annual Meeting Society for Investigative Dermatology","author":"Prost","year":"1996","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-51","first-page":"3\u20139","volume-title":"Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: A study by indirect immunoelectron microscopy","author":"B\u00e9dane","year":"1991","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-52","doi-asserted-by":"crossref","unstructured":"Letko E, Bhol K, Foster SC, Ahmed RA. Influence of intravenous immunoglobulin therapy on serum levels of anti-beta 4 antibodies in ocular cicatricial pemphigoid. A correlation with disease activity. A preliminary study. Curr Eye Res 2000;21:646\u2013654.","DOI":"10.1076\/0271-3683(200008)2121-VFT646"},{"key":"key-10.4103\/2008-322X.256557-53","first-page":"998\u20131004","volume-title":"Cicatricial pemphigoid with circulating autoantibodies to beta4 integrin, bullous pemphigoid 180, and bullous pemphigoid 230","author":"Leverkus","year":"2001","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-54","first-page":"233\u2013237","volume-title":"Oral mucous membrane pemphigoid.A study of sixty-five patients","author":"Silverman","year":"1986","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"key-10.4103\/2008-322X.256557-55","first-page":"501\u2013506","volume-title":"Subconjunctival mitomycin C for the treatment of ocular cicatricial pemphigoid","author":"Celis","year":"2002","journal-title":"Arch Soc Esp Oftalmol"},{"key":"key-10.4103\/2008-322X.256557-56","doi-asserted-by":"crossref","unstructured":"Kirtschig G, Murrell D, Wojnarowska F, Khumalo N. Interventions for mucous membrane pemphigoid and epidermolysis bullosa acquisita. Cochrane Database Syst Rev 2003;CD004056.","DOI":"10.1002\/14651858.CD004056"},{"key":"key-10.4103\/2008-322X.256557-57","first-page":"1268\u20131270","volume-title":"Successful treatment of mucous membrane pemphigoid with infliximab","author":"Heffernan","year":"2006","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-58","first-page":"786\u2013789","volume-title":"Treatment of ocular inflammatory disorders with daclizumab","author":"Papaliodis","year":"2003","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-59","first-page":"352\u2013356","volume-title":"Rituximab in autoimmune bullous diseases: Mixed responses and adverse effects","author":"Schmidt","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-60","first-page":"1772\u20131779","volume-title":"Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin","author":"Ahmed","year":"2006","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-322X.256557-61","first-page":"1604\u20131610","volume-title":"Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid","author":"G\u00fcrcan","year":"2007","journal-title":"Ann Pharmacother"},{"key":"key-10.4103\/2008-322X.256557-62","first-page":"557\u2013578","volume-title":"Use of intravenous immunoglobulin therapy in autoimmune blistering diseases","author":"Ahmed","year":"2006","journal-title":"Int Immunopharmacol"},{"key":"key-10.4103\/2008-322X.256557-63","first-page":"1380\u20131382","volume-title":"Intravenous immunoglobulin therapy in patients with ocular-cicatricial pemphigoid: A long-term follow-up","author":"Sami","year":"2004","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-64","first-page":"421\u2013426","volume-title":"Successful transplantation of bioengineered tissue replacements in patients with ocular surface disease","author":"Schwab","year":"2000","journal-title":"Cornea"},{"key":"key-10.4103\/2008-322X.256557-65","first-page":"38\u201352","volume-title":"Surgical reconstruction of the ocular surface in advanced ocular cicatricial pemphigoid and Stevens-Johnson syndrome","author":"Tsubota","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-66","first-page":"862\u2013868","volume-title":"Limbal stem cell transplantation in chronic inflammatory eye disease","author":"Samson","year":"2002","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-67","first-page":"1569\u20131574","volume-title":"Cultivated corneal epithelial stem cell transplantation in ocular surface disorders","author":"Koizumi","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-68","first-page":"126\u2013133","volume-title":"Living related conjunctival limbal allograft for the treatment of stem cell deficiency","author":"Daya","year":"2001","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-69","first-page":"86\u201393","volume-title":"Reconstruction of damaged corneas by transplantation of autologous limbal epithelial cells","author":"Tsai","year":"2000","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-322X.256557-70","first-page":"956\u2013961","volume-title":"The Boston keratoprosthesis type I in mucous membrane pemphigoid","author":"Palioura","year":"2013","journal-title":"Cornea"},{"key":"key-10.4103\/2008-322X.256557-71","first-page":"27\u201335","volume-title":"Long-term visual outcomes and complications of Boston keratoprosthesis type II implantation","author":"Lee","year":"2017","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-72","first-page":"1319\u20131329","volume-title":"Modified osteo-odonto-keratoprosthesis for treatment of corneal blindness: Long-term anatomical and functional outcomes in 181 cases","author":"Falcinelli","year":"2005","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-73","unstructured":"Amagai M. Pemphigus. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. St. Louis, MO: Elsevier; 2012. p. 461."},{"key":"key-10.4103\/2008-322X.256557-74","first-page":"7658\u20137662","volume-title":"Major histocompatibility complex haplotype studies in Ashkenazi Jewish patients with pemphigus vulgaris","author":"Ahmed","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.256557-75","first-page":"5056\u20135060","volume-title":"Major histocompatibility complex haplotypes and class II genes in non-Jewish patients with pemphigus vulgaris","author":"Ahmed","year":"1991","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key-10.4103\/2008-322X.256557-76","first-page":"52\u201358","volume-title":"Genotyping for HLA-A, B and C alleles in Japanese patients with pemphigus: Prevalence of Asian alleles of the HLA-B15 family","author":"Miyagawa","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-77","first-page":"615\u2013618","volume-title":"HLA-DRB1 * 04 and DRB1 * 14 alleles are associated with susceptibility to pemphigus among Japanese","author":"Miyagawa","year":"1997","journal-title":"J Invest Dermatol"},{"key":"key-10.4103\/2008-322X.256557-78","first-page":"61\u201373","volume-title":"Pemphigus","author":"Bystryn","year":"2005","journal-title":"Lancet"},{"key":"key-10.4103\/2008-322X.256557-79","first-page":"63\u201375","volume-title":"Ocular cicatricial pemphigoid and ocular manifestations of pemphigus vulgaris","author":"Smith","year":"1997","journal-title":"Int Ophthalmol Clin"},{"key":"key-10.4103\/2008-322X.256557-80","first-page":"1076\u20131083","volume-title":"Presence of interleukin 10 in the serum and blister fluid of patients with pemphigus vulgaris and pemphigoid","author":"Bhol","year":"2000","journal-title":"Cytokine"},{"key":"key-10.4103\/2008-322X.256557-81","first-page":"226\u2013234","volume-title":"Immunodiagnosis of pemphigus and mucous membrane pemphigoid","author":"Challacombe","year":"2001","journal-title":"Acta Odontol Scand"},{"key":"key-10.4103\/2008-322X.256557-82","first-page":"725; author reply 725\u2013726","volume-title":"Ocular involvement in pemphigus vulgaris","author":"Tenner","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-83","first-page":"356\u2013361","volume-title":"Epidemiologic survey of pemphigus vulgaris with oral manifestations in northern Greece: Retrospective study of 129 patients","author":"Michailidou","year":"2007","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-84","first-page":"365\u2013368","volume-title":"Conjunctival blistering associated with pemphigus vulgaris: Report of a case","author":"Bianciotto","year":"2005","journal-title":"Arch Soc Esp Oftalmol"},{"key":"key-10.4103\/2008-322X.256557-85","first-page":"1\u20133","volume-title":"Response of ocular pemphigus vulgaris to therapy.Case report and review of literature","author":"Olszewska","year":"2008","journal-title":"J Dermatol Case Rep"},{"key":"key-10.4103\/2008-322X.256557-86","unstructured":"Baer JC, Hemady RK. Ocular manifestations of systemic immune disease. In: Bosniak S, ed. Principles and Practice of Ophthalmic Plastic and Reconstructive Surgery, vol 1. Philadelphia, PA: WB Saunders Company; 1996. p. 94\u2013119."},{"key":"key-10.4103\/2008-322X.256557-87","first-page":"585\u2013590","volume-title":"Ocular pemphigus","author":"Daoud","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-88","first-page":"1767\u20131779","volume-title":"Autoimmune bullous diseases: Ocular manifestations and management","author":"Laforest","year":"2005","journal-title":"Drugs"},{"key":"key-10.4103\/2008-322X.256557-89","first-page":"183\u2013185","volume-title":"Pemphigus vulgaris: The eyes have it","author":"Merchant","year":"2003","journal-title":"Pediatrics"},{"key":"key-10.4103\/2008-322X.256557-90","first-page":"73\u201374","volume-title":"Severe conjunctival and eyelid involvement in pemphigus vulgaris","author":"Lifshitz","year":"2004","journal-title":"Int Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-91","first-page":"618\u2013621","volume-title":"Ocular involvement in pemphigus vulgaris","author":"Akhyani","year":"2014","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-92","first-page":"149\u2013152","volume-title":"Ocular involvement in pemphigus","author":"Palleschi","year":"2007","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-93","first-page":"119\u2013136","volume-title":"Ocular manifestations of blistering diseases","author":"Elchahal","year":"2008","journal-title":"Immunol Allergy Clin North Am"},{"key":"key-10.4103\/2008-322X.256557-94","first-page":"230\u2013239","volume-title":"Bullous autoimmune diseases of the oral mucosa","author":"Vaillant","year":"1999","journal-title":"Rev Stomatol Chir Maxillofac"},{"key":"key-10.4103\/2008-322X.256557-95","first-page":"1083\u20131084","volume-title":"Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment","author":"Hall","year":"2003","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-96","first-page":"28\u201335","volume-title":"Use of recombinant pemphigus vulgaris antigen in development of ELISA and IB assays to detect pemphigus vulgaris autoantibodies","author":"Bhol","year":"1998","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"key-10.4103\/2008-322X.256557-97","unstructured":"Kavosh ER, Bielory L. Allergic disease of the eye. In: Mahmoudi M, editor. Allergy and Asthma: Practical Diagnosis and Management. 1st ed. New York: McGraw Hill; 2007. p. 21\u201331."},{"key":"key-10.4103\/2008-322X.256557-98","first-page":"365\u2013368","volume-title":"Triamcinolone acetonide for rare ocular manifestations of pemphigus vulgaris: A case report","author":"Kozeis","year":"2010","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-99","first-page":"503\u2013511","volume-title":"Paraneoplastic pemphigus","author":"Zhu","year":"2007","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-100","first-page":"619\u2013626","volume-title":"Sensitivity and specificity of clinical, histologic, and immunologic features in the diagnosis of paraneoplastic pemphigus","author":"Joly","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-101","first-page":"649\u2013671","volume-title":"The new pemphigus variants","author":"Robinson","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-102","first-page":"725\u2013732","volume-title":"Paraneoplastic pemphigus in children and adolescents","author":"Mimouni","year":"2002","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-103","first-page":"1729\u20131735","volume-title":"Paraneoplastic pemphigus.An autoimmune mucocutaneous disease associated with neoplasia","author":"Anhalt","year":"1990","journal-title":"N Engl J Med"},{"key":"key-10.4103\/2008-322X.256557-104","first-page":"1500\u20131502","volume-title":"Paraneoplastic pemphigus with autoantibody deposition in bronchial epithelium after autologous bone marrow transplantation","author":"Fullerton","year":"1992","journal-title":"J Am Med Assoc"},{"key":"key-10.4103\/2008-322X.256557-105","first-page":"108\u2013113","volume-title":"Paraneoplastic pemphigus, cicatricial conjunctivitis, and acanthosis nigricans with pachydermatoglyphy in a patient with bronchogenic squamous cell carcinoma","author":"Lam","year":"1992","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-106","first-page":"607\u2013612","volume-title":"Current management strategies in paraneoplastic pemphigus (paraneoplastic autoimmune multiorgan syndrome)","author":"Frew","year":"2011","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/2008-322X.256557-107","first-page":"372\u2013376","volume-title":"Paraneoplastic pemphigus in association with a retroperitoneal Castleman's disease presenting with a lichen planus pemphigoides-like eruption.A case report and review of literature","author":"Hsiao","year":"2001","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-108","first-page":"77\u201396; discussion 97","volume-title":"Paraneoplastic pemphigus","author":"Anhalt","year":"1997","journal-title":"Adv Dermatol"},{"key":"key-10.4103\/2008-322X.256557-109","first-page":"775\u2013782","volume-title":"Antibodies against desmoglein 3 (pemphigus vulgaris antigen) are present in sera from patients with paraneoplastic pemphigus and cause acantholysis in vivo in neonatal mice","author":"Amagai","year":"1998","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-110","first-page":"955\u2013959","volume-title":"Castleman's disease associated with pemphigus vulgaris","author":"Gili","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-111","unstructured":"Tam PM, Cheng LL, Young AL, Lam PT. Paraneoplastic pemphigus: An uncommon cause of chronic cicatrising conjunctivitis. BMJ Case Rep 2009;2009. doi: 10.1136\/bcr. 12.2008.1306."},{"key":"key-10.4103\/2008-322X.256557-112","first-page":"147\u2013150","volume-title":"Bilateral corneal melting in a patient with paraneoplastic pemphigus","author":"Beele","year":"2001","journal-title":"Dermatology"},{"key":"key-10.4103\/2008-322X.256557-113","first-page":"1084\u20131089","volume-title":"Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: A case report and review of cases treated with rituximab","author":"Anan","year":"2011","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-114","first-page":"621\u2013624","volume-title":"Conjunctival involvement in paraneoplastic pemphigus","author":"Meyers","year":"1992","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-115","first-page":"105\u2013106","volume-title":"Paraneoplastic pemphigus in two patients with B-cell non-Hodgkin's lymphoma: Significant responses to cyclophosphamide and prednisolone","author":"Hertzberg","year":"2000","journal-title":"Am J Hematol"},{"key":"key-10.4103\/2008-322X.256557-116","first-page":"506\u2013508","volume-title":"Use of mycophenolate mofetil in the treatment of paraneoplastic pemphigus","author":"Williams","year":"2000","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-117","first-page":"196\u2013198","volume-title":"Paraneoplastic pemphigus associated with Hodgkin's disease","author":"Dega","year":"1998","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-118","first-page":"547\u2013553","volume-title":"Paraneoplastic pemphigus: A report of three cases including one long-term survivor","author":"Camisa","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-119","first-page":"127\u2013137","volume-title":"New and emerging therapies in the treatment of blistering diseases","author":"Korman","year":"2000","journal-title":"Dermatol Clin"},{"key":"key-10.4103\/2008-322X.256557-120","first-page":"526\u2013529","volume-title":"Retroperitoneal round-cell liposarcoma associated with paraneoplastic pemphigus presenting as lichen planus pemphigoides-like eruption","author":"Krunic","year":"1997","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-121","first-page":"285\u2013286","volume-title":"Case of paraneoplastic pemphigus with follicular lymphoma treated with rituximab","author":"Aoi","year":"2013","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-122","first-page":"142\u2013144","volume-title":"Successful treatment of paraneoplastic pemphigus in follicular NHL with rituximab: Report of a case and review of treatment for paraneoplastic pemphigus in NHL and CLL","author":"Heizmann","year":"2001","journal-title":"Am J Hematol"},{"key":"key-10.4103\/2008-322X.256557-123","first-page":"503\u2013508","volume-title":"Rituximab in refractory autoimmune bullous diseases","author":"Schmidt","year":"2006","journal-title":"Clinical and Exp Dermatol"},{"key":"key-10.4103\/2008-322X.256557-124","first-page":"659\u2013664","volume-title":"Paraneoplastic conjunctival cicatrization: Two different pathogenic types","author":"Ahuero","year":"2010","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-125","first-page":"383\u2013392","volume-title":"Linear IgA bullous dermatosis of adults","author":"Chorzelski","year":"1991","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2008-322X.256557-126","first-page":"48\u201352","volume-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions.Bullous Diseases French Study Group","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-127","first-page":"867\u2013875","volume-title":"Adult linear IgA disease and chronic bullous disease of childhood: The association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression","author":"Collier","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-128","first-page":"52\u201356","volume-title":"Linear IgA disease: A heterogeneous disease","author":"Wojnarowska","year":"1994","journal-title":"Dermatology"},{"key":"key-10.4103\/2008-322X.256557-129","first-page":"393\u2013401","volume-title":"Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood)","author":"Jab\u0142o\u0144ska","year":"1991","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2008-322X.256557-130","first-page":"340\u2013343","volume-title":"Linear IgA disease.The ocular manifestations","author":"Aultbrinker","year":"1988","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-131","first-page":"316\u2013323","volume-title":"Drug-induced linear IgA bullous dermatosis after vancomycin discontinuance in a patient with renal insufficiency","author":"Klein","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-132","first-page":"759\u2013764","volume-title":"Drug-induced linear IgA bullous dermatosis","author":"Onodera","year":"2005","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-133","first-page":"608\u2013612","volume-title":"Captopril-triggered linear IgA bullous dermatosis","author":"Friedman","year":"1998","journal-title":"Int J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-134","first-page":"187\u2013192","volume-title":"Drug-induced linear IgA bullous dermatosis: Report of six cases and review of the literature","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-135","first-page":"809\u2013811","volume-title":"Amiodarone-induced linear IgA disease","author":"Primka","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-136","first-page":"352\u2013356","volume-title":"Phenytoin-induced linear IgA bullous disease","author":"Acostamadiedo","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-137","first-page":"161\u2013170","volume-title":"A clinicopathological study of mucosal involvement in linear IgA disease","author":"Kelly","year":"1988","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-138","first-page":"792\u2013805","volume-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults.A comparative study demonstrating clinical and immunopathologic overlap","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-139","first-page":"1438\u20131442","volume-title":"A child with antibodies targeting both linear IgA bullous dermatosis and bullous pemphigoid antigens","author":"Darling","year":"1995","journal-title":"Arch Dermatol"},{"key":"key-10.4103\/2008-322X.256557-140","first-page":"64\u201366","volume-title":"Antigenic specificity of antibodies from patients with linear basement membrane deposition of IgA","author":"Zone","year":"1994","journal-title":"Dermatology"},{"key":"key-10.4103\/2008-322X.256557-141","first-page":"1\u20138","volume-title":"Clinical, demographic, and immunohistologic features of vancomycin-induced linear IgA bullous disease of the skin.Report of 2 cases and review of the literature","author":"Nousari","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"key-10.4103\/2008-322X.256557-142","first-page":"90\u201391","volume-title":"Linear IgA bullous dermatosis of childhood: Treatment with dapsone and co-trimoxazole","author":"Pulimood","year":"1997","journal-title":"Clin Exp Dermatol"},{"key":"key-10.4103\/2008-322X.256557-143","first-page":"50\u201352","volume-title":"Treatment of linear IgA bullous dermatosis of childhood with colchicine","author":"Ang","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"key-10.4103\/2008-322X.256557-144","first-page":"960\u2013967","volume-title":"High-dose intravenous immunoglobulins for the treatment of autoimmune mucocutaneous blistering diseases: Evaluation of its use in 19 cases","author":"Segura","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"key-10.4103\/2008-322X.256557-145","first-page":"1524\u20131528","volume-title":"Linear IgA bullous disease limited to the eye: A diagnostic dilemma: Response to intravenous immunoglobulin therapy","author":"Letko","year":"2000","journal-title":"Ophthalmology"},{"key":"key-10.4103\/2008-322X.256557-146","first-page":"582","volume-title":"High-dose intravenous immune globulin is also effective in linear IgA disease","author":"Kroiss","year":"2000","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-147","first-page":"932\u2013933","volume-title":"Treatment of epidermolysis bullosa acquisita with mycophenolate mofetil and autologous keratinocyte grafting","author":"Schattenkirchner","year":"1999","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-148","first-page":"397\u2013399","volume-title":"Epidermolysis bullosa acquisita responsive to dapsone therapy","author":"Hughes","year":"2001","journal-title":"J Cutan Med Surg"},{"key":"key-10.4103\/2008-322X.256557-149","first-page":"6514\u20136521","volume-title":"The alternative pathway of complement activation is critical for blister induction in experimental epidermolysis bullosa acquisita","author":"Mihai","year":"2007","journal-title":"J Immunol"},{"key":"key-10.4103\/2008-322X.256557-150","first-page":"125\u2013129","volume-title":"Immunofluorescence studies using skin sections of recessive dystrophic epidermolysis bullosa patients indicated that the antigen of anti-p200 pemphigoid is not a fragment of type VII collagen","author":"Liu","year":"2003","journal-title":"J Dermatol Sci"},{"key":"key-10.4103\/2008-322X.256557-151","first-page":"775\u2013777","volume-title":"Blindness due to the IgA variant of epidermolysis bullosa acquisita, and treatment with osteo-odonto-keratoprosthesis","author":"Cox","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-152","first-page":"825\u2013828","volume-title":"The pathophysiology of autoimmune blistering diseases","author":"Yancey","year":"2005","journal-title":"J Clin Invest"},{"key":"key-10.4103\/2008-322X.256557-153","first-page":"2009\u20132018","volume-title":"The cartilage matrix protein subdomain of type VII collagen is pathogenic for epidermolysis bullosa acquisita","author":"Chen","year":"2007","journal-title":"Am J Pathol"},{"key":"key-10.4103\/2008-322X.256557-154","first-page":"226\u2013229","volume-title":"Epidermolysis bullosa acquisita in childhood","author":"Trigo-Guzm\u00e1n","year":"2003","journal-title":"J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-155","first-page":"115\u2013116, 118\u2013121","volume-title":"Rituximab (anti-CD20) for the treatment of autoimmune bullous diseases","author":"Kasperkiewicz","year":"2007","journal-title":"Der Hautarzt"},{"key":"key-10.4103\/2008-322X.256557-156","first-page":"1615\u20131618","volume-title":"Chronic cicatrizing conjunctivitis in a patient with epidermolysis bullosa acquisita","author":"Letko","year":"2006","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/2008-322X.256557-157","first-page":"129\u2013138","volume-title":"Bullous systemic lupus erythematosus","author":"Vassileva","year":"2004","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2008-322X.256557-158","first-page":"20\u201325","volume-title":"Autoimmune bullous diseases: Diagnosis and management","author":"McCuin","year":"2006","journal-title":"Dermatol Nurs"},{"key":"key-10.4103\/2008-322X.256557-159","first-page":"86","volume-title":"Epidermolysis bullosa acquisita","author":"Das","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"key-10.4103\/2008-322X.256557-160","first-page":"417\u2013419","volume-title":"Treatment-resistant classical epidermolysis bullosa acquisita responding to rituximab","author":"Sadler","year":"2007","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-161","first-page":"550\u2013558","volume-title":"Epidermolysis bullosa acquisita: Clinical manifestations, microscopic findings, and surgical periodontal therapy.A case report","author":"Hakki","year":"2001","journal-title":"J Periodontol"},{"key":"key-10.4103\/2008-322X.256557-162","first-page":"520\u2013531","volume-title":"Experimental models of epidermolysis bullosa acquisita","author":"Sitaru","year":"2007","journal-title":"Exp Dermatol"},{"key":"key-10.4103\/2008-322X.256557-163","first-page":"843\u2013851","volume-title":"Epidermolysis bullosa acquisita sera react with distinct epitopes on the NC1 and NC2 domains of type VII collagen: Study using immunoblotting of domain-specific recombinant proteins and postembedding immunoelectron microscopy","author":"Ishii","year":"2004","journal-title":"Br J Dermatol"},{"key":"key-10.4103\/2008-322X.256557-164","first-page":"72","volume-title":"Epidermolysis bullosa acquisita treated with basiliximab, an interleukin-2 receptor antibody","author":"Haufs","year":"2001","journal-title":"Acta Derm Venereol"},{"key":"key-10.4103\/2008-322X.256557-165","first-page":"712\u2013718","volume-title":"Epidermolysis bullosa acquisita: Update and review","author":"Hallel-Halevy","year":"2001","journal-title":"Clin Dermatol"},{"key":"key-10.4103\/2008-322X.256557-166","first-page":"15","volume-title":"Epidermolysis bullosa acquisita","author":"Stein","year":"2007","journal-title":"Dermatol Online J"},{"key":"key-10.4103\/2008-322X.256557-167","first-page":"1385\u20131386","volume-title":"IgM-mediated epidermolysis bullosa acquisita","author":"Suchniak","year":"2002","journal-title":"Arch Dermatol"}],"container-title":["Journal of Ophthalmic and Vision Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T15:21:07Z","timestamp":1734448867000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jovr.org\/text.asp?2019\/14\/2\/195\/256557"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019]]}},"alternative-id":["256557"],"URL":"https:\/\/doi.org\/10.4103\/jovr.jovr_86_18","relation":{},"ISSN":["2008-322X"],"issn-type":[{"value":"2008-322X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}